On April 23, 2025, a Virginia Beach-based psychiatry nurse practitioner posted in a private Facebook group asking for reviews. “Would anyone be willing to endorse Google reviews?” they wrote. “We can ...

VIENNA — Oral semaglutide showed similar reductions in cardiovascular events in patients with type 2 diabetes (T2D) and cardiovascular or chronic kidney disease with and without peripheral artery ...

Among patients in a lung cancer screening registry, cancer survivors had similar outcomes as those with no prior cancer — but their rate of lung cancer detection was numerically higher. Cancer ...

Remibrutinib is the first Bruton tyrosine kinase inhibitor approved by the FDA for chronic spontaneous urticaria.

Emergency department (ED) mortality rose, and transfers from the ED and the ICU increased in the wake of a facility’s private equity (PE) acquisition, a new study shows. Researchers from the ...

Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ICD candidates.

Cost, access, treatment burden, and a lack of high-quality data may explain why apheresis is seldom used to lower lipoprotein(a) in at-risk patients.

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease ( COPD) and T2 ...

Differentiate between acute and chronic, recognize symptoms, and offer evidence-based dietary interventions to address root causes.

PARIS — Doses of interleukin (IL) 17 and IL-23 inhibitors were safely reduced in people with plaque psoriasis who had “very stable low disease activity”; it was reported during a late-breaking news ...

A new Cochrane review bolsters confidence in the safety and effectiveness of RSV vaccines for older adults and pregnant people.

At the 28th World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO 2025), Marianela Aguirre Ackermann, MD, presented that limited awareness, stigma, ...